Detail page

Knowledge Web

Person

Matthias Schwenkglenks (1965-)

Gesundheitswissenschaftler

Name	Matthias Schwenkglenks
Time	1965- (Date of birth and death)
Place	Schweiz
Gender	männlich
Academic degree	Dr.
Profession	Gesundheitswissenschaftler (characteristic profession) Soziologe
Variant	Matthias Michael Schwenkglenks
Related	Universität Zürich. Institut für Epidemiologie, Biostatistik und Prävention Universität Basel Epidemiologie (Thema)
Further information	Institute of Pharmaceutical Medicine (ECPM), University of Basel, Switzerland
Source	Helveticat, SAP Uni Basel Homepage: https://www.ebpi.uzh.ch/en/aboutus/departments/epidemiology/cde/groupleaderscde/schwenkglenks.html (Stand: 03.01.2019)
Record type	Person
GND-Identifier	1089799403
Record ID	1089799403
Involved in show all Individualized Treatment Rules Based on Cost-Effectiveness Criteria in Microsimulations Correction: The association between medication use and health-related quality of life in multimorbid older patients with polypharmacy MultiSCRIPT-Cycle 1—a pragmatic trial embedded within the Swiss Multiple Sclerosis Cohort (SMSC) on neurofilament light chain monitoring to inform personalized treatment decisions in multiple sclerosis: a study protocol for a randomized clinical trial The association between medication use and health-related quality of life in multimorbid older patients with polypharmacy Correction: A mixed methods analysis of the medication review intervention centered around the use of the ‘Systematic Tool to Reduce Inappropriate Prescribing’ Assistant (STRIPA) in Swiss primary care practices Cost-Effectiveness Analysis of Etranacogene Dezaparvovec Versus Extended Half-Life Prophylaxis for Moderate-to-Severe Haemophilia B in Germany A mixed methods analysis of the medication review intervention centered around the use of the ‘Systematic Tool to Reduce Inappropriate Prescribing’ Assistant (STRIPA) in Swiss primary care practices Benzodiazepine Receptor Agonists Use and Cessation Among Multimorbid Older Adults with Polypharmacy: Secondary Analysis from the OPERAM Trial Factors associated with health-related quality of life among home-dwelling older adults aged 75 or older in Switzerland: a cross-sectional study Correction to: Cost-Effectiveness, Burden of Disease and Budget Impact of Inclisiran: Dynamic Cohort Modelling of a Real-World Population with Cardiovascular Disease Cost-effectiveness of voretigene neparvovec in the treatment of patients with inherited retinal disease with RPE65 mutation in Switzerland Cost-Effectiveness, Burden of Disease and Budget Impact of Inclisiran: Dynamic Cohort Modelling of a Real-World Population with Cardiovascular Disease Association of pulmonary vein isolation and major cardiovascular events in patients with atrial fibrillation Health and social care of home-dwelling frail older adults in Switzerland: a mixed methods study Reporting quality of clinical trial protocols: a repeated cross-sectional study about the Adherence to SPIrit Recommendations in Switzerland, CAnada and GErmany (ASPIRE-SCAGE) Cost–utility analysis of risk-reducing strategies to prevent breast and ovarian cancer in BRCA-mutation carriers in Switzerland Cost-effectiveness and budget impact of venetoclax in combination with rituximab in relapsed/refractory chronic lymphocytic leukemia in Switzerland The INSPIRE Population Survey: development, dissemination and respondent characteristics Baseline characteristics and comparability of older multimorbid patients with polypharmacy and general practitioners participating in a randomized controlled primary care trial Cost Effectiveness and Budget Impact of Siponimod Compared to Interferon Beta-1a in the Treatment of Adult Patients with Secondary Progressive Multiple Sclerosis with Active Disease in Switzerland Systematic early versus late mobilization or standard early mobilization in mechanically ventilated adult ICU patients: systematic review and meta-analysis Temporal trends and regional disparities in cancer screening utilization: an observational Swiss claims-based study Going beyond the mean: economic benefits of myocardial infarction secondary prevention Degree of regional variation and effects of health insurance-related factors on the utilization of 24 diverse healthcare services - a cross-sectional study Rationale and design of repeated cross-sectional studies to evaluate the reporting quality of trial protocols: the Adherence to SPIrit REcommendations (ASPIRE) study and associated projects Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacy Use of selective serotonin reuptake inhibitors, other antidepressant medication, and risk of cataract: a case-control study based on Swiss claims data Exploring geographic variation of and influencing factors for utilization of four diabetes management measures in Swiss population using claims data Variation of colorectal, breast and prostate cancer screening activity in Switzerland: influence of insurance, policy and guidelines Physical Activity Interventions for Primary Prevention in Adults: A Systematic Review of Randomized Controlled Trial-Based Economic Evaluations Economic burden of symptomatic iron deficiency – a survey among Swiss women Variation of preoperative chest radiography utilization in Switzerland and its influencing factors: a multilevel study with claims data How much does the treatment of each major disease cost? A decomposition of Swiss National Health Accounts Glucocorticoids and the Risk of Peptic Ulcer Bleeding: Case–Control Analysis Based on Swiss Claims Data Variation of preoperative chest radiography utilization in Switzerland and its influencing factors: a multilevel study with claims data Benzodiazepine Use and Risk of Developing Alzheimer’s Disease: A Case-Control Study Based on Swiss Claims Data Clinical and genetic risk factors for epirubicin-induced cardiac toxicity in early breast cancer patients Efficacy, effectiveness and safety of long-acting granulocyte colony-stimulating factors for prophylaxis of chemotherapy-induced neutropenia in patients with cancer: a systematic review Epidemiology and costs of diabetes mellitus in Switzerland: an analysis of health care claims data, 2006 and 2011 Delivery of health care at the end of life in cancer patients of four swiss cantons: a retrospective database study (SAKK 89/09) Multivariable regression analysis of febrile neutropenia occurrence in early breast cancer patients receiving chemotherapy assessing patient-related, chemotherapy-related and genetic risk factors Erratum to: Impact of febrile neutropenia on R-CHOP chemotherapy delivery and hospitalizations among patients with diffuse large B-cell lymphoma Learning from failure - rationale and design for a study about discontinuation of randomized trials (DISCO study) Evaluating the impact of Relative Total Dose Intensity (RTDI) on patients' short and long-term outcome in taxane- and anthracycline-based chemotherapy of metastatic breast cancer- a pooled analysis Diagnostic accuracy of point-of-care testing for acute coronary syndromes, heart failure and thromboembolic events in primary care: a cluster-randomised controlled trial Risk factors for chemotherapy-induced neutropenia occurrence in breast cancer patients: data from the INC-EU Prospective Observational European Neutropenia Study Cost-Effectiveness of Eplerenone in Patients with Left Ventricular Dysfunction after Myocardial Infarction—An Analysis of the EPHESUS Study from a Swiss Perspective Neutropenic event risk and impaired chemotherapy delivery in six European audits of breast cancer treatment Epidemiology and costs of gastroesophageal reflux disease in Switzerland: a population-based study

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Matthias Schwenkglenks (1965-)

Individualized Treatment Rules Based on Cost-Effectiveness Criteria in Microsimulations

Correction: The association between medication use and health-related quality of life in multimorbid older patients with polypharmacy

MultiSCRIPT-Cycle 1—a pragmatic trial embedded within the Swiss Multiple Sclerosis Cohort (SMSC) on neurofilament light chain monitoring to inform personalized treatment decisions in multiple sclerosis: a study protocol for a randomized clinical trial

The association between medication use and health-related quality of life in multimorbid older patients with polypharmacy

Correction: A mixed methods analysis of the medication review intervention centered around the use of the ‘Systematic Tool to Reduce Inappropriate Prescribing’ Assistant (STRIPA) in Swiss primary care practices

Cost-Effectiveness Analysis of Etranacogene Dezaparvovec Versus Extended Half-Life Prophylaxis for Moderate-to-Severe Haemophilia B in Germany

A mixed methods analysis of the medication review intervention centered around the use of the ‘Systematic Tool to Reduce Inappropriate Prescribing’ Assistant (STRIPA) in Swiss primary care practices

Benzodiazepine Receptor Agonists Use and Cessation Among Multimorbid Older Adults with Polypharmacy: Secondary Analysis from the OPERAM Trial

Factors associated with health-related quality of life among home-dwelling older adults aged 75 or older in Switzerland: a cross-sectional study

Correction to: Cost-Effectiveness, Burden of Disease and Budget Impact of Inclisiran: Dynamic Cohort Modelling of a Real-World Population with Cardiovascular Disease

Cost-effectiveness of voretigene neparvovec in the treatment of patients with inherited retinal disease with RPE65 mutation in Switzerland

Cost-Effectiveness, Burden of Disease and Budget Impact of Inclisiran: Dynamic Cohort Modelling of a Real-World Population with Cardiovascular Disease

Association of pulmonary vein isolation and major cardiovascular events in patients with atrial fibrillation

Health and social care of home-dwelling frail older adults in Switzerland: a mixed methods study

Reporting quality of clinical trial protocols: a repeated cross-sectional study about the Adherence to SPIrit Recommendations in Switzerland, CAnada and GErmany (ASPIRE-SCAGE)

Cost–utility analysis of risk-reducing strategies to prevent breast and ovarian cancer in BRCA-mutation carriers in Switzerland

Cost-effectiveness and budget impact of venetoclax in combination with rituximab in relapsed/refractory chronic lymphocytic leukemia in Switzerland

The INSPIRE Population Survey: development, dissemination and respondent characteristics

Baseline characteristics and comparability of older multimorbid patients with polypharmacy and general practitioners participating in a randomized controlled primary care trial

Cost Effectiveness and Budget Impact of Siponimod Compared to Interferon Beta-1a in the Treatment of Adult Patients with Secondary Progressive Multiple Sclerosis with Active Disease in Switzerland

Systematic early versus late mobilization or standard early mobilization in mechanically ventilated adult ICU patients: systematic review and meta-analysis

Temporal trends and regional disparities in cancer screening utilization: an observational Swiss claims-based study

Going beyond the mean: economic benefits of myocardial infarction secondary prevention

Degree of regional variation and effects of health insurance-related factors on the utilization of 24 diverse healthcare services - a cross-sectional study

Rationale and design of repeated cross-sectional studies to evaluate the reporting quality of trial protocols: the Adherence to SPIrit REcommendations (ASPIRE) study and associated projects

Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacy

Use of selective serotonin reuptake inhibitors, other antidepressant medication, and risk of cataract: a case-control study based on Swiss claims data

Exploring geographic variation of and influencing factors for utilization of four diabetes management measures in Swiss population using claims data

Variation of colorectal, breast and prostate cancer screening activity in Switzerland: influence of insurance, policy and guidelines

Physical Activity Interventions for Primary Prevention in Adults: A Systematic Review of Randomized Controlled Trial-Based Economic Evaluations

Economic burden of symptomatic iron deficiency – a survey among Swiss women

Variation of preoperative chest radiography utilization in Switzerland and its influencing factors: a multilevel study with claims data

How much does the treatment of each major disease cost? A decomposition of Swiss National Health Accounts

Glucocorticoids and the Risk of Peptic Ulcer Bleeding: Case–Control Analysis Based on Swiss Claims Data

Variation of preoperative chest radiography utilization in Switzerland and its influencing factors: a multilevel study with claims data

Benzodiazepine Use and Risk of Developing Alzheimer’s Disease: A Case-Control Study Based on Swiss Claims Data

Clinical and genetic risk factors for epirubicin-induced cardiac toxicity in early breast cancer patients

Efficacy, effectiveness and safety of long-acting granulocyte colony-stimulating factors for prophylaxis of chemotherapy-induced neutropenia in patients with cancer: a systematic review

Epidemiology and costs of diabetes mellitus in Switzerland: an analysis of health care claims data, 2006 and 2011

Delivery of health care at the end of life in cancer patients of four swiss cantons: a retrospective database study (SAKK 89/09)

Multivariable regression analysis of febrile neutropenia occurrence in early breast cancer patients receiving chemotherapy assessing patient-related, chemotherapy-related and genetic risk factors

Erratum to: Impact of febrile neutropenia on R-CHOP chemotherapy delivery and hospitalizations among patients with diffuse large B-cell lymphoma

Learning from failure - rationale and design for a study about discontinuation of randomized trials (DISCO study)

Evaluating the impact of Relative Total Dose Intensity (RTDI) on patients' short and long-term outcome in taxane- and anthracycline-based chemotherapy of metastatic breast cancer- a pooled analysis

Diagnostic accuracy of point-of-care testing for acute coronary syndromes, heart failure and thromboembolic events in primary care: a cluster-randomised controlled trial

Risk factors for chemotherapy-induced neutropenia occurrence in breast cancer patients: data from the INC-EU Prospective Observational European Neutropenia Study

Cost-Effectiveness of Eplerenone in Patients with Left Ventricular Dysfunction after Myocardial Infarction—An Analysis of the EPHESUS Study from a Swiss Perspective

Neutropenic event risk and impaired chemotherapy delivery in six European audits of breast cancer treatment

Epidemiology and costs of gastroesophageal reflux disease in Switzerland: a population-based study